Clinical Trial Update: Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on modified tumor-infiltrating lymphocytes for metastatic melanoma; trial status is terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Melanoma, Skin Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-03-21